Choong Ang Vaccine Laboratory Co. Ltd (072020) - Net Assets

Latest as of March 2026: ₩106.81 Billion KRW ≈ $72.39 Million USD

Based on the latest financial reports, Choong Ang Vaccine Laboratory Co. Ltd (072020) has net assets worth ₩106.81 Billion KRW (≈ $72.39 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩124.42 Billion ≈ $84.32 Million USD) and total liabilities (₩17.61 Billion ≈ $11.93 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Choong Ang Vaccine Laboratory Co. Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩106.81 Billion
% of Total Assets	85.85%
Annual Growth Rate	6.63%
5-Year Change	13.33%
10-Year Change	74.55%
Growth Volatility	8.17

Choong Ang Vaccine Laboratory Co. Ltd - Net Assets Trend (2014–2025)

This chart illustrates how Choong Ang Vaccine Laboratory Co. Ltd's net assets have evolved over time, based on quarterly financial data. See Choong Ang Vaccine Laboratory Co. Ltd (072020) defensive interval to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Choong Ang Vaccine Laboratory Co. Ltd (2014–2025)

The table below shows the annual net assets of Choong Ang Vaccine Laboratory Co. Ltd from 2014 to 2025. For live valuation and market cap data, see Choong Ang Vaccine Laboratory Co. Ltd (072020) total market value.

Year	Net Assets	Change
2025-12-31	₩105.37 Billion ≈ $71.41 Million	+1.45%
2024-12-31	₩103.87 Billion ≈ $70.39 Million	+4.07%
2023-12-31	₩99.80 Billion ≈ $67.64 Million	+4.72%
2022-12-31	₩95.30 Billion ≈ $64.59 Million	+2.50%
2021-12-31	₩92.98 Billion ≈ $63.01 Million	+6.20%
2020-12-31	₩87.55 Billion ≈ $59.33 Million	+1.37%
2019-12-31	₩86.37 Billion ≈ $58.53 Million	+1.60%
2018-12-31	₩85.00 Billion ≈ $57.61 Million	+31.43%
2017-12-31	₩64.68 Billion ≈ $43.83 Million	+7.14%
2016-12-31	₩60.37 Billion ≈ $40.91 Million	+9.99%
2015-12-31	₩54.88 Billion ≈ $37.19 Million	+5.56%
2014-12-31	₩51.99 Billion ≈ $35.23 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Choong Ang Vaccine Laboratory Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 99.2% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	₩76.53 Billion	72.63%
Other Components	₩28.84 Billion	27.37%
Total Equity	₩105.37 Billion	100.00%

Choong Ang Vaccine Laboratory Co. Ltd Competitors by Market Cap

The table below lists competitors of Choong Ang Vaccine Laboratory Co. Ltd ranked by their market capitalization.

Company	Market Cap
Raonsecure Co. Ltd KQ:042510	$61.73 Million
Evertex Fabrinology Ltd TW:1470	$61.74 Million
Kredyt Inkaso SA WAR:KRI	$61.76 Million
PUBLIC POLICY HO.COM 144A F:PD7	$61.79 Million
Byuksan Corp KO:007210	$61.69 Million
Ama Marine Public Company Limited BK:AMA	$61.67 Million
China Tianrui Group Cement Company Limited F:T18	$61.67 Million
Glomac Bhd KLSE:5020	$61.66 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Choong Ang Vaccine Laboratory Co. Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 103,867,274,100 to 105,369,001,400, a change of 1,501,727,300 (1.4%).
Net income of 6,156,817,310 contributed positively to equity growth.
Dividend payments of 1,624,976,790 reduced retained earnings.
Share repurchases of 3,006,519,780 reduced equity.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩6.16 Billion	+5.84%
Dividends Paid	₩1.62 Billion	-1.54%
Share Repurchases	₩3.01 Billion	-2.85%
Other Changes	₩-23.59 Million	-0.02%
Total Change	₩-	1.45%

Book Value vs Market Value Analysis

This analysis compares Choong Ang Vaccine Laboratory Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.86x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.46x to 0.86x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩6651.35	₩9730.00	x
2017-12-31	₩7126.31	₩9730.00	x
2018-12-31	₩8535.70	₩9730.00	x
2019-12-31	₩8672.55	₩9730.00	x
2020-12-31	₩8880.48	₩9730.00	x
2021-12-31	₩9527.51	₩9730.00	x
2022-12-31	₩9859.41	₩9730.00	x
2023-12-31	₩10333.10	₩9730.00	x
2024-12-31	₩10866.27	₩9730.00	x
2025-12-31	₩11258.95	₩9730.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Choong Ang Vaccine Laboratory Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 5.84%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 12.55%
• Asset Turnover: 0.40x
• Equity Multiplier: 1.17x
Recent ROE (5.84%) is below the historical average (6.02%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	8.24%	14.47%	0.49x	1.17x	₩-914.44 Million
2015	5.93%	9.40%	0.56x	1.13x	₩-2.23 Billion
2016	10.29%	16.38%	0.52x	1.22x	₩172.74 Million
2017	7.08%	14.37%	0.39x	1.26x	₩-1.89 Billion
2018	4.06%	10.42%	0.34x	1.14x	₩-5.05 Billion
2019	2.15%	5.64%	0.34x	1.12x	₩-6.78 Billion
2020	3.61%	8.71%	0.35x	1.20x	₩-5.59 Billion
2021	8.18%	18.58%	0.36x	1.21x	₩-1.70 Billion
2022	4.24%	10.29%	0.34x	1.21x	₩-5.49 Billion
2023	6.01%	14.33%	0.35x	1.20x	₩-3.98 Billion
2024	6.59%	15.02%	0.37x	1.19x	₩-3.54 Billion
2025	5.84%	12.55%	0.40x	1.17x	₩-4.38 Billion

Industry Comparison

This section compares Choong Ang Vaccine Laboratory Co. Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $329,362,045,253
Average return on equity (ROE) among peers: 3.99%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Choong Ang Vaccine Laboratory Co. Ltd (072020)	₩106.81 Billion	8.24%	0.16x	$61.71 Million
Dongwha Pharm.Co.Ltd (000020)	$297.40 Billion	3.39%	0.25x	$97.49 Million
Yuhan Corp. (000100)	$519.03 Billion	9.81%	0.47x	$3.90 Billion
Yuhan Corp Preferred (000105)	$1.65 Trillion	3.48%	0.32x	$51.83 Million
Yuyu Pharma (000220)	$128.69 Billion	-1.72%	0.50x	$43.48 Million
Yuyu Pharma Inc (000225)	$120.36 Billion	-5.97%	0.65x	$14.47 Million
Yuyu Pharma Inc (000227)	$86.87 Billion	4.63%	0.56x	$42.09 Million
Ildong Holdings Co Ltd (000230)	$55.81 Billion	8.24%	2.38x	$53.57 Million
Samil Pharm (000520)	$54.41 Billion	1.08%	0.83x	$101.43 Million
Donga Socio Holdings (000640)	$266.72 Billion	7.48%	1.59x	$367.37 Million
Jw Pharmac (001060)	$112.60 Billion	9.51%	2.66x	$416.42 Million

About Choong Ang Vaccine Laboratory Co. Ltd

KQ:072020 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$61.71 Million

₩91.06 Billion KRW

Market Cap Rank

#21129 Global

#1201 in Korea

Share Price

₩9730.00

Change (1 day)

+0.62%

52-Week Range

₩8780.00 - ₩10140.00

All Time High

₩30815.73